- Home
- ACDC vs IMTX Comparison
ACDC vs IMTX Comparison
Compare ACDC & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACDC
- IMTX
- Stock Information
- Founded
- ACDC 2014
- IMTX N/A
- Country
- ACDC United States
- IMTX Germany
- Employees
- ACDC N/A
- IMTX N/A
- Industry
- ACDC Oilfield Services/Equipment
- IMTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ACDC Energy
- IMTX Health Care
- Exchange
- ACDC Nasdaq
- IMTX Nasdaq
- Market Cap
- ACDC 1.1B
- IMTX 954.2M
- IPO Year
- ACDC 2022
- IMTX N/A
- Fundamental
- Price
- ACDC $9.02
- IMTX $5.40
- Analyst Decision
- ACDC Hold
- IMTX Strong Buy
- Analyst Count
- ACDC 5
- IMTX 4
- Target Price
- ACDC $7.40
- IMTX $16.67
- AVG Volume (30 Days)
- ACDC 389.8K
- IMTX 988.8K
- Earning Date
- ACDC 03-12-2025
- IMTX 11-18-2024
- Dividend Yield
- ACDC N/A
- IMTX N/A
- EPS Growth
- ACDC N/A
- IMTX N/A
- EPS
- ACDC N/A
- IMTX N/A
- Revenue
- ACDC $2,225,300,000.00
- IMTX $128,824,447.00
- Revenue This Year
- ACDC N/A
- IMTX $116.22
- Revenue Next Year
- ACDC N/A
- IMTX N/A
- P/E Ratio
- ACDC N/A
- IMTX N/A
- Revenue Growth
- ACDC N/A
- IMTX 52.53
- 52 Week Low
- ACDC $5.16
- IMTX $5.28
- 52 Week High
- ACDC $9.75
- IMTX $13.77
- Technical
- Relative Strength Index (RSI)
- ACDC 63.33
- IMTX 22.73
- Support Level
- ACDC $7.60
- IMTX $5.28
- Resistance Level
- ACDC $8.51
- IMTX $7.42
- Average True Range (ATR)
- ACDC 0.53
- IMTX 0.40
- MACD
- ACDC 0.14
- IMTX -0.13
- Stochastic Oscillator
- ACDC 82.33
- IMTX 4.98
About ACDC ProFrac Holding Corp.
ProFrac Holding Corp is engaged in providing hydraulic fracturing, completion services, and other complementary products and services to upstream oil and gas companies engaged in the exploration and production of North American unconventional oil and natural gas resources. Its operations are focused in West Texas, East Texas/Louisiana, South Texas, Oklahoma, Uinta, and Appalachian. The company operates in three segments: stimulation services, manufacturing, and proppant production. Stimulation services, which generate the majority of the revenue for the company operate a fleet of mobile hydraulic fracturing units and other auxiliary equipment that generates revenue by providing stimulation services.
About IMTX Immatics N.V.
Immatics NV is a biotechnology company that is engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies.